Cargando…
Immune monitoring technology primer: immunosequencing
BACKGROUND: Profiling of the immune receptor repertoire is becoming increasingly relevant to the understanding and clinical management of cancer, autoimmunity, aging, and infectious disease. FINDINGS: A platform technology is described that provides comprehensive immune receptor profiling. CONCLUSIO...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480450/ https://www.ncbi.nlm.nih.gov/pubmed/26113978 http://dx.doi.org/10.1186/s40425-015-0076-y |
_version_ | 1782378162839093248 |
---|---|
author | Kirsch, Ilan |
author_facet | Kirsch, Ilan |
author_sort | Kirsch, Ilan |
collection | PubMed |
description | BACKGROUND: Profiling of the immune receptor repertoire is becoming increasingly relevant to the understanding and clinical management of cancer, autoimmunity, aging, and infectious disease. FINDINGS: A platform technology is described that provides comprehensive immune receptor profiling. CONCLUSION: Immunosequencing is a platform technology that allows the enumeration, specification and quantification of each and every B-and/or T-cell in any biologic sample of interest. It is based on bias-controlled multiplex PCR and high throughput sequencing and is highly accurate, standardized, and sensitive. |
format | Online Article Text |
id | pubmed-4480450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44804502015-06-26 Immune monitoring technology primer: immunosequencing Kirsch, Ilan J Immunother Cancer Short Report BACKGROUND: Profiling of the immune receptor repertoire is becoming increasingly relevant to the understanding and clinical management of cancer, autoimmunity, aging, and infectious disease. FINDINGS: A platform technology is described that provides comprehensive immune receptor profiling. CONCLUSION: Immunosequencing is a platform technology that allows the enumeration, specification and quantification of each and every B-and/or T-cell in any biologic sample of interest. It is based on bias-controlled multiplex PCR and high throughput sequencing and is highly accurate, standardized, and sensitive. BioMed Central 2015-06-25 /pmc/articles/PMC4480450/ /pubmed/26113978 http://dx.doi.org/10.1186/s40425-015-0076-y Text en © Kirsch. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Kirsch, Ilan Immune monitoring technology primer: immunosequencing |
title | Immune monitoring technology primer: immunosequencing |
title_full | Immune monitoring technology primer: immunosequencing |
title_fullStr | Immune monitoring technology primer: immunosequencing |
title_full_unstemmed | Immune monitoring technology primer: immunosequencing |
title_short | Immune monitoring technology primer: immunosequencing |
title_sort | immune monitoring technology primer: immunosequencing |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480450/ https://www.ncbi.nlm.nih.gov/pubmed/26113978 http://dx.doi.org/10.1186/s40425-015-0076-y |
work_keys_str_mv | AT kirschilan immunemonitoringtechnologyprimerimmunosequencing |